Cohesion among key stakeholders, which will lead to an evolution in care, is clearly on the rise, and the growth of those relationships will only benefit patients in the end.
Becky Rand, Vice President of Manufacturer Relations, ExceleraRx Corp.
Advertisement
Articles by Becky Rand, Vice President of Manufacturer Relations, ExceleraRx Corp.
Advertisement
Latest Updated Articles
Health Systems’ Role in Specialty Pharmacy Moves Into Focus at AsembiaPublished: June 14th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
4
Expert Discusses Early Safety and Tolerability Findings for VMT-α-NET in Neuroendocrine Tumors | ESMO 2025
5
